tirzepatide l carnitine vs tirzepatide tirzepatide/l-carnitine L-Carnitine – MCCM Medical Cosmetics GLP-1 Additives: B12, L-Carnitine &

| Substance | Receptor profile | Trial | Weight change | Placebo | | --- | --- | --- | --- | --- | | Retatrutide | GIP/GLP-1/glucagon | Phase 2 (48 wk) | -8.7 to -24.2 % | -2.1 % | | Tirzepatide | GIP/GLP-1 | SURMOUNT-1 (72 wk) | -16.0 to -22.5 % | -3.1 % | | Semaglutide | GLP-1 | STEP 1 (68 wk) | -14.9 % | -2.4 % | | Cagrilintide + semaglutide | Amylin + GLP-1 | Phase 1b (20 wk) | -15.7 to -17.1 % | -9.8 %* | | CagriSema | Amylin + GLP-1 | REDEFINE 1 (68 wk) | -20.4 % | -3.0 % | *Comparator arm semaglutide alone

Instead of pushing every patient to the maximum dose, clinicians may maintain individuals at lower doses that still produce meaningful metabolic effects

Gene symbols (italicized) indicate mouse transcripts

Additional information FDA Disclaimer: The statements made regarding these products have not been evaluated by the U.S

10.1016/j.ijid.2021.03.032 150 PareekM.GreenawayC.NooriT.MunozJ.ZennerD

Patient assistance programs may provide free medication for qualifying low-income individuals